Artelo Biosciences Limited — Sponsor Intelligence | 1 EU Trials

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

1 Recruiting

0 Completed trials

2 Countries active

2 Unique IMPs

N/A Results reported

Phase I (FiH)

Top IMPs

1 total

A Phase 1/2 Trial of the Synthetic Cannabinoid ART27.13 in Patients with Cancer Anorexia and Weight Loss Recruiting

2024-518177-33-00 Phase I (FiH) 2 countries N-{2-TERT-BUTYL-1-[(4,4-DIFLUOROCYCLOHEXYL)METHYL]-1H-1,3-BENZODIAZOL-5-YL}ETHAN…

Showing 1–1 of 1 trials